Welcome to our dedicated page for Xtrackers Japan JPX-Nikkei 400 Equity ETF news (Ticker: JPN), a resource for investors and traders seeking the latest updates and insights on Xtrackers Japan JPX-Nikkei 400 Equity ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Xtrackers Japan JPX-Nikkei 400 Equity ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Xtrackers Japan JPX-Nikkei 400 Equity ETF's position in the market.
DWS has announced the closure and liquidation of two Xtrackers ETFs: the Xtrackers Eurozone Equity ETF (Cboe BZX: EURZ) and the Xtrackers Japan JPX-Nikkei 400 Equity ETF (NYSE Arca: JPN). Both funds will stop accepting creation orders after March 7, 2022, and will cease trading on the same date. Liquidation proceeds are expected to be distributed to shareholders around March 16, 2022. Shareholders can sell their holdings until market close on March 7, incurring typical transaction fees. The announcement comes amidst DWS managing $1.05 trillion in assets as of December 31, 2021.
